Touching Base
by Genetic Engineering & Biotechnology News (GEN)
Is this your podcast?Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 13 chart positions in 13 markets.
By chart position
- 🇦🇺AU · Life Sciences#9930K to 100K
- 🇩🇪DE · Life Sciences#1805K to 30K
- 🇯🇵JP · Life Sciences#9110K to 30K
- 🇰🇷KR · Life Sciences#10010K to 30K
- 🇮🇹IT · Life Sciences#1521K to 10K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
36K to 129K🎙 ~2x weekly·47 episodes·Last published 1mo ago - Monthly Reach
Unique listeners across all episodes (30 days)
72K to 258K🇦🇺39%🇩🇪12%🇯🇵12%+10 more - Active Followers
Loyal subscribers who consistently listen
22K to 77K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 16 epsHosts
Recent guests
Recent episodes
Parkinson’s in the Clinic, Insilico enters Phase III, Vertex Acquires Crinetics
Jul 17, 2026
32m 22s
Merck and Insilico Make Deals, Claude Science’s Debut, Vaccines for Neglected Diseases
Jul 2, 2026
35m 34s
Historic Biotech IPO, Merck, Protillion’s AI Deal, Testing a Lassa–Rabies Vaccine
Jun 18, 2026
34m 42s
A Billion-Dollar Deal, Trial Trouble, Biohub Updates, and Vaccine Research News
Jun 4, 2026
37m 21s
AI Scientists, Stock Tumble, Patent Lawsuit, and New Partnerships
May 22, 2026
32m 13s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 7/17/26 | Parkinson's disease therapystem cell therapy+4 | — | InsilicoVertex+2 | — | Parkinson's diseasestem cells+6 | — | 32m 22s | ||
| 7/2/26 | biotech dealsartificial intelligence+4 | — | Merck KGaABio-Techne+5 | — | Merck KGaABio-Techne+5 | — | 35m 34s | ||
| 6/18/26 | biotech fundraisingbig pharma deals+4 | — | Parabilis MedicinesMerck+2 | — | biotechIPO+7 | — | 34m 42s | ||
| 6/4/26 | biotech newsvaccine research+4 | — | Fulcrum TherapeuticsFDA+4 | — | sickle cell diseaseRNA exon editors+3 | — | 37m 21s | ||
| 5/22/26 | AI in sciencebiotech news+3 | Alex PhilippidisFay Lin, PhD+1 | Google DeepMindEdison+6 | — | AI Scientistsbiotech+3 | — | 32m 13s | ||
| 5/7/26 | J. Craig Venterhuman genome+4 | John SterlingKevin Davies, PhD+1 | Genetic Engineering & Biotechnology News | — | J. Craig Venterhuman genome+5 | — | 43m 51s | ||
| 4/23/26 | AI in oncologyHIV research+4 | — | CAR T cell therapypancreatic cancer drug+5 | — | AIoncology+6 | — | 33m 23s | ||
| 4/9/26 | AI in drug designbiotech news+4 | — | WegovyFoundayo+6 | — | AIdrug design+7 | — | 31m 49s | ||
| 3/26/26 | agentic AIregenerative medicine+3 | — | LNPsmRNA Vaccine+7 | — | agentic AIXaira Therapeutics+5 | — | 39m 43s | ||
| 3/13/26 | bacterial simulationgene editing+4 | — | J. Craig Venter InstituteuniQure+1 | — | bacteriagene insertion+5 | — | 41m 02s | ||
| 2/27/26 | artificial intelligenceFDA news+3 | — | Tamarind BioU.S. Food and Drug Administration+6 | — | artificial intelligenceFDA+4 | — | 38m 54s | ||
| 2/13/26 | Women in ScienceRobotics+4 | Michelle Lee | MedraEli Lilly+2 | — | Women in ScienceRobotics+6 | — | 32m 44s | ||
| 1/30/26 | legal developmentsbiotech news+5 | — | CytoDyn10x Genomics+3 | — | CytoDyn10x Genomics+5 | — | 34m 17s | ||
| 12/18/25 | AI in drug discoverycell and gene therapy+3 | — | ElevidysGEN+3 | — | AIdrug discovery+6 | — | 41m 00s | ||
| 12/4/25 | lung organoidsautism+4 | — | iPSC-derived lung organoidssmall-molecule pharmacological chaperones+5 | — | lung organoidsautism+5 | — | 35m 56s | ||
| 11/20/25 | nasal vaccinesbiotech news+4 | — | KorroJohnson & Johnson+10 | — | nasal vaccinesHPV+7 | — | 41m 50s |
Showing 16 of 16
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Chart history for Touching Base
Peaked at #36 in TH, currently #36 in TH.
| Market | Genre | Peak | Current | Trend |
|---|---|---|---|---|
| TH | — | #36 | #36 | — |
| MY | — | #67 | #67 | — |
| Japan | — | #91 | #91 | — |
| Australia | — | #99 | #99 | — |
| South Korea | — | #100 | #100 | — |
| SG | — | #118 | #118 | — |
| IL | — | #136 | #136 | — |
| TW | — | #139 | #139 | — |
| BE | — | #147 | #147 | — |
| Norway | — | #150 | #150 | — |
| Italy | — | #152 | #152 | — |
| AT | — | #168 | #168 | — |
| Germany | — | #180 | #180 | — |
Chart Positions
13 placements across 13 markets.
Chart Positions
13 placements across 13 markets.